首页 | 本学科首页   官方微博 | 高级检索  
     


Preventive migraine treatment with eptinezumab reduced acute headache medication and headache frequency to below diagnostic thresholds in patients with chronic migraine and medication-overuse headache
Authors:Michael J. Marmura MD  Hans-Christoph Diener MD  PhD  Robert P. Cowan MD  FAAN  Stewart J. Tepper MD  Merle L. Diamond MD  Amaal J. Starling MD  Joe Hirman PhD  Lahar Mehta MD  Thomas Brevig MD  PhD  Roger Cady MD
Affiliation:1. Department of Neurology, Jefferson Headache Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA;2. Institute for Medical Informatics, Biometry and Epidemiology, Medical Faculty, University of Duisburg-Essen, Essen, Germany;3. Department of Neurology and Neurological Sciences, Stanford University Headache and Facial Pain Program, Palo Alto, California, USA;4. Department of Neurology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA;5. Diamond Headache Clinic, Chicago, Illinois, USA;6. Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA;7. Pacific Northwest Statistical Consulting, Inc., Woodinville, Washington, USA;8. Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, Washington, USA;9. H. Lundbeck A/S, Copenhagen, Denmark;10. Lundbeck La Jolla Research Center, San Diego, California, USA
Abstract:
Keywords:acute headache medication use  chronic migraine  eptinezumab  medication-overuse headache
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号